Non-Sterile Compounding Pharmacy Market Outlook 2025–2032: Size, Trends & Players According to a newly published market research report by 24LifeSciences, global non-sterile compounding pharmacy market is valued at USD 595 million in 2026 and is projected to reach USD 694 million by 2034, growing at a compound annual growth rate (CAGR) of 2.3% during the forecast period. Non-sterile compounding involves the customized preparation of medications for oral, topical, nasal, otic, or rectal administration, tailored to meet specific patient needs unavailable in commercial formulations. This practice requires strict adherence to regulatory standards like USP Chapter <795>, ensuring product integrity, accurate dosing, and patient safety. Its critical role in personalized medicine makes it indispensable for populations requiring unique formulations, including pediatric, geriatric, and patients with allergies or sensitivities to standard drug excipients. Download a Free Sample Report (PDF): https://www.24lifesciences.com/download-sample/9556/non-sterile-compounding-pharmacy-market